Assessing TransMedics Gr: Insights From 6 Financial Analysts
Assessing TransMedics Gr: Insights From 6 Financial Analysts
評估 transmedics Gr：來自6位財務分析師的見解
Across the recent three months, 6 analysts have shared their insights on TransMedics Gr (NASDAQ:TMDX), expressing a variety of opinions spanning from bullish to bearish.
在最近的三個月中，有6位分析師分享了他們對TransMedics Gr (NASDAQ:TMDX)的觀點，表達了從看好到看淡的各種意見。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $160.17, a high estimate of $200.00, and a low estimate of $120.00. Marking an increase of 33.7%, the current average surpasses the previous average price target of $119.80.
分析師12個月的目標價預測揭示了平均目標價爲160.17美元，最高預估爲200.00美元，最低預估爲120.00美元的各種預測。當前的平均目標價比之前的平均目標價119.80美元增長了33.7%。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查：一項詳盡的研究
The analysis of recent analyst actions sheds light on...
最近分析師行動分析...
登入免費觀看全文
登入/註冊